John Suk

Mr. John Suk is currently the owner of Altmax Consulting, a Canadian healthcare consulting company. After holding senior executive roles at McNeil Labs (Johnson & Johnson), GlaxoSmithKline plc, and Hoffman La Roche, in 1997, Mr. Suk founded Byk Canada (later known as Nycomed), a subsidiary of German company Byk Gulden. In the fourteen years Mr. Suk served as President and CEO of Nycomed, the company’s sales volume blossomed to over $300 million. From 2006 to 2017, Mr. Suk served on the Board of Directors of Brock University and was Chair of Brock’s Board of Trustees from 2013 through 2016. He has also served on the Board of Canada’s Research-Based Pharmaceutical Companies (Rx&D), a national association representing the voice of Canada’s innovative pharmaceutical industry. He has also served on the Boards of the Health Research Foundation, Innovate Niagara, IIX Technologies, Medical Futures, and Exciton Technologies. Mr. Suk holds an Advanced Management Certificate from Insead, the professional ICD.D designation from Rotman School of Management at the University of Toronto, and an H.B.Sc from Brock University.